The quiet end of the spectrum: A case report and review of “simple schizophrenia”
- 2 November 2026
- journal article
- review article
- Published by SAGE Publications in Australasian Psychiatry
Abstract
Background: Schizophrenia is increasingly understood as a neurodevelopmental disorder in which cognitive and negative symptoms may precede or overshadow florid psychosis. Such neuropsychiatric presentations can be difficult to recognise within current diagnostic frameworks that privilege positive symptoms. Objective: To illustrate a schizophrenia presentation without hallucinations and delusions and to contextualise it within contemporary and historical nosology. Methods: Single case report with a focussed narrative review of the literature on simple schizophrenia subtypes. Case: a 24-year-old woman experienced a two-year insidious decline in motivation, social engagement, and cognition, with prominent affective flattening, avolition, bradyphrenia, poverty of speech, and psychomotor slowing. There were no delusions or hallucinations, and thought form was linear. Extensive investigations including MRI, EEG, FDG-PET, and CSF studies were unremarkable. Neuropsychological testing showed deficits in new learning, processing speed, and executive functioning consistent with schizophrenia-spectrum illness. The illness was refractory to multiple antidepressants, antipsychotics, and a course of electroconvulsive therapy. Following exclusion of organic pathology, multidisciplinary assessment, and longitudinal review, a diagnosis of schizophrenia was formulated. Conclusion: Current diagnostic systems may overlook individuals with schizophrenia without hallucinations or delusions. Incorporating neuropsychiatric markers and establishing cognitive trajectories into diagnostic thinking may enable earlier identification and more targeted interventions.Keywords
This publication has 34 references indexed in Scilit:
- The hypothesis of biologically based subtypes of schizophrenia: a 10‐year updateWorld Psychiatry, 2025
- Treatment for Negative Symptoms in Schizophrenia: A Comprehensive ReviewDrugs, 2017
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trialThe Lancet, 2017
- Schizophrenia, primary negative symptoms, and soft outcomes in psychiatryThe Lancet, 2017
- Schizophrenia Is a Cognitive IllnessJAMA Psychiatry, 2013
- The Nosology of SchizophreniaPsychiatric Clinics of North America, 2012
- En defensa del diagnóstico de esquizofrenia simple: reflexiones a propósito de un casoRevista de Psiquiatría y Salud Mental, 2012
- A Separate Disease Within the Syndrome of SchizophreniaArchives of General Psychiatry, 2001
- The neo-Kraepelinian revolution in psychiatric diagnosisEuropean Archives of Psychiatry and Clinical Neuroscience, 1995
- The schedule for the deficit syndrome: An instrument for research in schizophreniaPsychiatry Research, 1989